A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 143

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 143
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 209
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 994
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3134
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 574
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 488
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Decreased Absolute Number of Circulating Regulatory T Cells in Patients With Takayasu's Arteritis. | LitMetric

AI Article Synopsis

  • Takayasu's arteritis (TA) is a serious vascular condition characterized by an imbalance in immune cell types, particularly a decrease in regulatory T cells (Tregs) and an increase in Th17 cells, which may contribute to the disease's relapse and activity.
  • A study involving 57 TA patients and 43 healthy controls found that TA patients had lower levels of Tregs and higher levels of pro-inflammatory cytokines (like IL-6 and TNF-α), particularly in those with active disease.
  • The research suggests that monitoring the levels of these immune cells and cytokines could provide insights into TA disease activity and treatment efficacy, indicating a potential target for improving patient outcomes.

Article Abstract

Background: Takayasu's arteritis (TA) is a type of primary large vessel vasculitis. Th1, Th17, and Tfh cells have been reported to be associated with TA relapse. However, the relationship between regulatory T cells (Tregs) and TA remains unclear.

Objective: To analyze the levels of circulating lymphocytes, especially Treg cells (CD4CD25FOXP3 T cells) and serum cytokines in TA patients and explore their relationship with their changes and TA disease activity.

Methods: A total of 57 TA patients and 43 sex- and age-matched healthy controls (HCs) were enrolled. According to NIH standards, 36 patients had active disease status. Flow cytometry combined with counting was used to detect the absolute numbers and ratios of Th1, Th2, Th17, and Treg cells in the peripheral blood of all the subjects. Magnetic bead-based multiplex immunoassay was used to detect cytokines.

Results: Compared to HCs, the absolute number and proportion of peripheral Treg cells in TA patients was significantly decreased, while Th17 cells were significantly increased. Furthermore, compared to the inactive group, the TA active group had significantly increased levels of interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α, but lower IL-10 levels. The absolute number of Th2 cells was negatively associated with platelet (PLT) and NIS scores in TA patients. The proportion of Th2 cells was negatively associated with the erythrocyte sedimentation rate in TA patients. After treatment, Treg cells were markedly increased.

Conclusion: There was a Th17-Treg cell imbalance with a significant reduction in peripheral Treg cells and an increase in Th17 cells in TA patients compared to the HCs. The levels of IL-6, IL-10, IL-17, and TNF-α appeared to be related to disease activity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732761PMC
http://dx.doi.org/10.3389/fimmu.2021.768244DOI Listing

Publication Analysis

Top Keywords

treg cells
20
cells
13
absolute number
12
cells patients
12
regulatory cells
8
patients
8
takayasu's arteritis
8
compared hcs
8
peripheral treg
8
th17 cells
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!